Studies in patients with multiple myeloma have found that CD38+ T regulatory (Treg) cells are more suppressive than CD38− Treg cells, consisting of a novel subpopulation of Tregs (CD41CD251CD127dim), which demonstrated superior autologous T-cell inhibitory capacities [44,57]. The gene discussed is CD38; the disease is plasma cell myeloma.